Original from: genomeweb
The US Food and Drug Administration has granted Emergency Use Authorization for Becton Dickinson’s monkeypox PCR test.
The assay, Viasure Monkeypox virus Real-Time PCR Reagents for BD Max System, is designed to qualitatively detect monkeypox virus DNA in human lesion swab samples from individuals suspected of monkeypox infection by their healthcare provider. While positive results are indicative of the presence of monkeypox virus DNA, clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status, the FDA said.
Since September, the FDA has been issuing EUAs for monkeypox tests. So far, Thermo Fisher, Quest Diagnostics, Roche, and Abbott have also nabbed EUAs for their monkeypox assays.
Source: Becton Dickinson Monkeypox PCR Assay Granted FDA Emergency Use Authorization
Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.